Back to results
US 8,475,763 B2Granted
Method of determining the course of treatment for a patient having adenocarcinoma
AssigneeActis, Ltd.
InventorMarlin O. Thurston
Life of this patent
Estimating the term…
Abstract
A method for detecting antigen associated with adenocarcinoma commences by forming a 124I conjugate of a preferential locator, such as an antibody, and introducing the conjugate into a patient suspected of having adenocarcinoma. Positron emission tomography (PET) scanning of the patient reveals sites of accumulated conjugate, such sites including lymph nodes. The course of treatment of the patient then is determined by the amount of revealed lymph nodes.
Claims4
A method for determining the course of treatment for a patient having adenocarcinoma by detecting an antigen associated with adenocarcinoma, which comprises the steps of:
- (a) forming a conjugate of 124I and a monoclonal antibody binds tumor-associated antigen (TAG-72);
- (b) introducing said conjugate into a patient suspected of having adenocarcinoma;
- (c) positron emission tomography (PET) scanning said patient to reveal sites of accumulated conjugate, said sites including lymph nodes;
- (d) determining the course of treatment of said patient by the amount of revealed lymph nodes.
1 more element
Dependencies are inferred from the claim text.